Literature DB >> 16418691

Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics.

Michael Oellerich1, Markus J Barten, Victor W Armstrong.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16418691     DOI： 10.1097/01.ftd.0000194503.85763.f5

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  7 in total

1.  Pharmacodynamics of T-cell function for monitoring immunosuppression.

Authors:  M J Barten; A Tarnok; J Garbade; H B Bittner; S Dhein; F W Mohr; J F Gummert
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

2.  Optimized lysis buffer reagents for solubilization and preservation of proteins from cells and tissues.

Authors:  Byeong Hee Hwang; Kenneth Y Tsai; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 3.  Cell-free DNA in the surveillance of heart transplant rejection.

Authors:  Dhruva Sharma; Ganapathy Subramaniam; Neha Sharma; Preksha Sharma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-02-02

4.  A review on therapeutic drug monitoring of immunosuppressant drugs.

Authors:  Niloufar Mohammadpour; Sepideh Elyasi; Naser Vahdati; Amir Hooshang Mohammadpour; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699

5.  Assessment of Immunological Biomarkers in the First Year after Heart Transplantation.

Authors:  Maja-Theresa Dieterlen; Katja John; Hartmuth B Bittner; Meinhard Mende; Attila Tarnok; Friedrich W Mohr; Markus J Barten
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

Review 6.  Oral cyclosporine treatment in dogs: a review of the literature.

Authors:  T M Archer; D M Boothe; V C Langston; C L Fellman; K V Lunsford; A J Mackin
Journal:  J Vet Intern Med       Date:  2013-12-16       Impact factor: 3.333

7.  Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.

Authors:  F Boix; I Legaz; A Minhas; R Alfaro; V Jiménez-Coll; A Mrowiec; H Martínez-Banaclocha; J A Galián; C Botella; M R Moya-Quiles; F Sanchez-Bueno; R Robles; J de la Peña-Moral; P Ramirez; J A Pons; A Minguela; M Muro
Journal:  Clin Exp Immunol       Date:  2020-10-29       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.